Dr Mehmet Unsal Calis, | |
6610 Upper York Rd, New Hope, PA 18938-9508 | |
(908) 208-2044 | |
Not Available |
Full Name | Dr Mehmet Unsal Calis |
---|---|
Gender | Male |
Speciality | Obstetrics & Gynecology |
Location | 6610 Upper York Rd, New Hope, Pennsylvania |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1699792689 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207V00000X | Obstetrics & Gynecology | MD061750L (Pennsylvania) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Mehmet Unsal Calis, 6610 Upper York Rd, New Hope, PA 18938-9508 Ph: (908) 208-2044 | Dr Mehmet Unsal Calis, 6610 Upper York Rd, New Hope, PA 18938-9508 Ph: (908) 208-2044 |
News Archive
As Liberia rebuilds a health care system decimated by the 2014 Ebola outbreak, understanding precisely how far citizens live from health facilities and its impact on seeking care can help shape new strategies to improve health care delivery and reduce geographic disparities.
Excelitas Technologies® Corp., a global technology leader focused on delivering innovative, customized photonic solutions, introduced today the Surface Mount 905 nm Pulsed Semiconductor Laser (SMD Laser), offering the capability of automated pick-and-place high-volume assembly.
DSM BioSolutions today announced that it has entered into an agreement with Laboratoires Mayoly Spindler, Chatou Cedex, France, for the manufacture of "MS1819" lipase.
Tarix Orphan LLC, a privately held biopharmaceutical company focused on the treatment of rare neuromuscular disorders and connective tissue diseases, today announced that the U.S. Food and Drug Administration has granted Fast Track Designation to TXA127 (angiotensin 1-7) to reduce skeletal muscle damage and fibrosis and thereby improve muscle strength in Duchenne Muscular Dystrophy (DMD) patients.
BrainScope Company, Inc. today announced a publication describing the use of its flagship product, BrainScope One, in an independent clinical trial demonstrating the potential reduction of one-third (33.3%) of unnecessary computed tomography scans of mildly presenting head injured patients in hospital emergency rooms.
› Verified 7 days ago